The evaluation of haemodynamic patterns in hypertensive patients by radionuclide
techniques and a tomographic gamma camera has revealed differences between older and …

Aim: To compare the vascular effects of lacidipine with those of other calcium antagonists.
Methods: A review of published studies. Results: Experimental studies have shown that for a …

Lacidipine is a calcium antagonist of the dihydropyridine group that is highly selective for
vascular tissues. It has been tested during the last few years for the treatment of arterial …

Similarities and dissimilarities of 3 third generation calcium antagonist (amlodipine,
lacidipine and lercanidipine) are presented. Lacidipine is characterized by prolonged …

Lacidipine is a new 1, 4-dihydropyridine (DHP) that induces a potent calcium antagonistic
activity on vascular preparations. It has a markedly slow rate of onset, but its effect is still …

In an open, multicenter study, the calcium antagonist lacidipine was tested for efficacy and
safety, particularly with respect to any influence on lipid and carbohydrate metabolism. The …

Synopsis Lacidipine is an orally administered calcium channel blocker of the
dihydropyridine class, which shows selectivity for vascular smooth muscle over cardiac …

Summary Abstract Lacidipine (Caldine®, Lacimen®, Lacipil®, Midotens®, Motens®) is a
once-daily, orally-administered, lipophilic dihydropyridine calcium antagonist with an …

Eleven centers in Tuscany, Italy, recruited 96 patients (aged 21-75 years) with mild-to-
moderate essential hypertension [diastolic blood pressure (DBP) 95-115 mm Hg; systolic …

The aim of this study was to compare the antihypertensive efficacy and tolerability of
lacidipine, a new dihydropyridine calcium antagonist, and slow-release nifedipine (SR) in …